Paradoxical Psoriasis Induced by Ustekinumab: A Comprehensive Review and Case Report
Medicina · 06.01.2024 · 60 (1) · 106
DOI: 10.3390/medicina60010106 ↗Kurz gefasst
Fallbericht in der Zeitschrift Medicina, online erschienen am 06.01.2024. Verfasst von Andrei Ovidiu Olteanu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, "Carol Davila" University of Medicine and Pharmacy, 020021 Bucharest, Romania. Hauptthemen laut MEDLINE: Crohn Disease, Psoriasis. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Medicine and Pharmacy Carol Davila.
Abstract (Originalsprache)
Ustekinumab (UST), a biologic agent targeting interleukin-12 and interleukin-23, is widely used in the management of psoriasis and Crohn’s disease. Despite its efficacy, there have been instances of paradoxical psoriasis induction or exacerbation in some patients during UST therapy. This paper offers a comprehensive review of reported cases of UST-induced paradoxical psoriasis, including a case from our clinic. We focus on a 39-year-old female patient with a history of long-standing Crohn’s disease who developed a psoriasiform rash, as confirmed by biopsy, while undergoing UST treatment. The patient’s clinical journey, from initial diagnosis through the complexities of treatment adjustments due to various complications including drug-induced lupus and the subsequent onset of psoriatic manifestations, provides insight into the challenges encountered in the clinical management of such cases. This review emphasizes the necessity for clinicians to recognize the possibility of paradoxical psoriasis in patients receiving UST treatment and calls for further research to better understand this phenomenon and devise effective management strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, "Carol Davila" University of Medicine and Pharmacy, 020021 Bucharest, Romania.
- Department of Gastroenterology, Elias Emergency University Hospital, 011461 Bucharest, Romania.
- Laboratory of Molecular Neuro-Oncology, Department of Neurology, University Hospital Zurich, 8091 Zürich, Switzerland.
- Department of Pediatrics, "Maria Sklodowska Curie" Clinical Emergency Hospital for Children, 077120 Bucharest, Romania.
- Department of Dermatology, "Carol Davila" University of Medicine and Pharmacy, 020021 Bucharest, Romania.
- Department of Dermatology, Elias Emergency University Hospital, 011461 Bucharest, Romania.
ORCID-Profile: Olguta Anca Orzan, Cristian Valentin Toma
Förderung
- University of Medicine and Pharmacy Carol Davila
Zitieren
APA
Olteanu, A. O., Klimko, A., Tieranu, I., Orzan, O. A., Toma, C. V., Ionescu, E. M., Preda, C. M., & Tieranu, C. G. (2024). Paradoxical Psoriasis Induced by Ustekinumab: A Comprehensive Review and Case Report. Medicina, 60(1), 106. https://doi.org/10.3390/medicina60010106
Vancouver
Olteanu AO, Klimko A, Tieranu I, Orzan OA, Toma CV, Ionescu EM, et al. Paradoxical Psoriasis Induced by Ustekinumab: A Comprehensive Review and Case Report. Medicina. 2024;60(1):106. doi:10.3390/medicina60010106
BibTeX
@article{Olteanu2024,
author = {Olteanu, Andrei Ovidiu and Klimko, Artsiom and Tieranu, Ioana and Orzan, Olguta Anca and Toma, Cristian Valentin and Ionescu, Elena Mirela and Preda, Carmen Monica and Tieranu, Cristian George},
title = {Paradoxical Psoriasis Induced by Ustekinumab: A Comprehensive Review and Case Report},
journal = {Medicina},
year = {2024},
volume = {60},
number = {1},
pages = {106},
doi = {10.3390/medicina60010106}
}
EUVIMED